PDCD1 and thyroid gland disorder: In response to anti-PD-1 immunotherapies, they include autoimmune hypothyroidism (2-10% of patients), hyperthyroidism (0.9-7.8%), and thyroiditis (0.34-6.5%), recently acknowledged to be part of the same autoimmune entity 15.